Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02900560
Title Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Translational Research in Oncology
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

Azacitidine + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.